Results 261 to 270 of about 205,038 (298)
Metformin: clinical use in type 2 diabetes
Elizabeth Sanchez-Rangel, S. Inzucchi
semanticscholar +1 more source
Long‐term remission in gout: Challenges and future opportunities
Prolonged hyperuricemia is a major risk factor for gout, which is now regarded as a curable disease. Awareness of the various factors that can trigger gout flares is essential for their prevention. An important determinant of treatment decisions and long‐term follow‐up is the quality of the clinician–patient relationship. The “treat‐to‐target” approach
Patapong Towiwat, Zhanguo Li
wiley +1 more source
Mendelian randomization analysis reveals causal effects of metformin on bipolar disorder risk. [PDF]
Li Z, Wang L, Sun X, Lin Y.
europepmc +1 more source
Immunomodulatory Biomaterials for Bone and Soft Tissue Chronic Inflammation Diseases
This review analyzes immunomodulatory biomaterial strategies for treating chronic inflammatory disorders in bone and soft tissues. It explores emerging mechanisms for resolving inflammation while promoting tissue regeneration, offering insights for developing targeted immunotherapeutic approaches that bridge material science with immunology for ...
Yiming Li +7 more
wiley +1 more source
Evaluation of the effects of metformin on gut functions and microbiota and their contribution to improving glucose tolerance in diabetic mice. [PDF]
Godet M +12 more
europepmc +1 more source
Hydrogel Microspheres for Biomedical Applications
Hydrogel microspheres (HMs) play pivotal roles in biomedical applications, such as drug delivery, cell culture, regenerative medicine, wound healing, and tumor immunity. This review focuses on the latest findings to provide a more comprehensive understanding of HMs for biomedical applications.
Yingkang Huang +11 more
wiley +1 more source
Metformin use despite contraindications in metformin-associated lactic acidosis. [PDF]
Yang CC +4 more
europepmc +1 more source
Epidemiology and organized testing for the diagnosis of prostate cancer in Sweden
Abstract Prostate cancer is the most diagnosed cancer and the leading cause of cancer‐related death among men in Sweden. The natural history and risk factors of prostate cancer, particularly within hereditary populations, have been extensively studied in the Swedish context. Despite the absence of national recommendations for prostate‐specific antigen (
Eugen Y. H. Wang
wiley +1 more source

